BioLineRx Ltd. (BLRX)
BLRX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.17
0.00% on the day
Market cap
$10.8M
Nano cap
Revenue · 2025
$1.2M
No prior year to compare
Net income · 2025
-$2.0M
-171.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1498403/000117891326001581/0001178913-26-001581-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLoss), period ending 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | BLRX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Israel |
| IPO year | Not reported by the screener |
| SEC CIK | 0001498403 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | L3 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.2M |
| Net income | -$2.0M |
| Operating income | Not in SEC XBRL data |
| Net margin | -171.7% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 9.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-10-02 |
| Latest annual report | 20-F | 2026-03-23 |
| Latest quarterly / interim | 6-K | 2026-09-24 |
Source: SEC EDGAR submissions feed, 616 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PHIO | Phio Pharmaceuticals Corp. | $0.9345 | +1.36% | $10.9M |
| KPRX | Kiora Pharmaceuticals Inc. | $2.47 | -3.52% | $10.9M |
| LTRN | Lantern Pharma Inc. | $0.7107 | -3.57% | $10.6M |
| BFRG | Bullfrog AI Holdings Inc. | $0.5689 | -2.55% | $10.5M |
| ENSC | Ensysce Biosciences Inc. | $0.5725 | +2.99% | $11.1M |
| ACTU | Actuate Therapeutics Inc. | $0.4663 | -27.56% | $11.2M |
| BIVI | BioVie Inc. | $1.20 | -9.09% | $10.4M |
| TPST | Tempest Therapeutics Inc. | $0.6813 | -8.27% | $11.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier